Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer

News
2020
2019
Archive

January 8, 2020

Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
January 8, 2020

Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
January 7, 2020

Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer
January 7, 2020

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutics and Digital Biomarker Technologies
December 19, 2019

RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing
December 19, 2019

IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors
December 18, 2019

Pear Therapeutics Announces First Patient Dosed in Part II of Pear-006 Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
December 17, 2019

TMRW Life Sciences Raises $25 Million in Series B Funding Led by 5AM Ventures
December 17, 2019

Homology Medicines Announces Encouraging Initial Clinical Data from its pheNIX Gene Therapy Trial for PKU
December 16, 2019

Homology Medicines Announces Peer-Reviewed Publication of Five-Year Retrospective Study Conducted in Collaboration with Two PKU Key Opinion Leaders Demonstrating Substantially Elevated Phe Levels in Adults with Classical PKU on Standard of Care